Prevalence and Risk Factors for Vitamin D Insufficiency Among Children With Epilepsy

被引:50
作者
Shellhaas, Renee A. [1 ]
Barks, Amanda K. [2 ]
Joshi, Sucheta M. [1 ]
机构
[1] Univ Michigan, Dept Pediat & Communicable Dis, Div Pediat Neurol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA
关键词
D DEFICIENCY; INTRACTABLE EPILEPSY; AMBULATORY PATIENTS; UNITED-STATES; BONE TURNOVER; CARBAMAZEPINE; VALPROATE; IMPACT;
D O I
10.1016/j.pediatrneurol.2010.03.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This cross-sectional study was designed to determine the prevalence of, and risk factors for, vitamin D insufficiency among children treated for epilepsy in a general pediatric neurology clinic. Included were 78 children with epilepsy, aged 3-17 years, treated by the authors between September 2008 and March 2009. Vitamin D levels and relevant risk factors were evaluated using multiple logistic regression. Of the 78 children, 41% were male and 81% were of European origin; the mean age was 11.64 +/- 4.37 years. 25-hydroxyvitamin D levels of 20 ng/mL were observed in 25% of the children and levels considered to be normal (>32 ng/mL) were observed in only 25%. Girls and children with elevated body mass index were at increased risk for low 25-hydroxyvitamin I). The odds ratio for low 25-hydroxyvitamin D was 4.07 for girls versus boys, with a 95% confidence interval of 1.18-13.97; for each 1-unit increase in body mass index, the odds ratio was 1.179, with a 95% confidence interval of 1.047-1.329. Use of newer antiepileptic drugs was not associated with altered risk, compared with older enzyme-inducing drugs. Vitamin D insufficiency was highly prevalent in this unselected population of children with epilepsy. Female sex and increased body mass index were significant risk factors for low vitamin D levels, but antiepileptic drug regimen was not. (C) 2010 by Elsevier Inc. All rights reserved.
引用
收藏
页码:422 / 426
页数:5
相关论文
共 30 条
  • [1] Altay EE, 2000, J PEDIATR ENDOCR MET, V13, P933
  • [2] Adverse effects of antiepileptic drugs on bone mineral density
    Babayigit, Arzu
    Dirik, Eray
    Bober, Ece
    Cakmakci, Handan
    [J]. PEDIATRIC NEUROLOGY, 2006, 35 (03) : 177 - 181
  • [3] Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet
    Bergqvist, A. G. Christina
    Schall, Joan I.
    Stallings, Virginia A.
    [J]. EPILEPSIA, 2007, 48 (01) : 66 - 71
  • [4] Evaluation of Bone Turnover in Epileptic Children Using Oxcarbazepine
    Cansu, Ali
    Yesilkaya, Ediz
    Serdaroglu, Ayse
    Hirfanoglu, Tugba Lueleci
    Camurdan, Orhun
    Gulbahar, Olem
    Gucuyener, Kivilcun
    Cinaz, Peyami
    [J]. PEDIATRIC NEUROLOGY, 2008, 39 (04) : 266 - 271
  • [5] Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy
    Daniels, Z. S.
    Nick, T. G.
    Liu, C.
    Cassedy, A.
    Glauser, T. A.
    [J]. NEUROLOGY, 2009, 73 (09) : 658 - 664
  • [6] Predictors of bone density in ambulatory patients on antiepileptic drugs
    El-Hajj Fuleihan, Ghada
    Dib, Lea
    Yamout, Bassem
    Sawaya, Raja
    Mikati, Mohamad A.
    [J]. BONE, 2008, 43 (01) : 149 - 155
  • [7] ESTRAGUARD P, 2005, ACTA NEUROL SCAND, V112, P277
  • [8] Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy
    Guo, CY
    Ronen, GM
    Atkinson, SA
    [J]. EPILEPSIA, 2001, 42 (09) : 1141 - 1147
  • [9] Vitamin D Status: Measurement, Interpretation, and Clinical Application
    Holick, Michael F.
    [J]. ANNALS OF EPIDEMIOLOGY, 2009, 19 (02) : 73 - 78
  • [10] Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001-2004
    Kumar, Juhi
    Muntner, Paul
    Kaskel, Frederick J.
    Hailpern, Susan M.
    Melamed, Michal L.
    [J]. PEDIATRICS, 2009, 124 (03) : E362 - E370